News | July 26, 2021
Panacea Biotec posts consolidated loss of Rs. 57.35 Cr in Q1FY22
It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.
It posted net (loss) of Rs.(34.13) crores for the period ended June 30, 2020.
The company reported total income of Rs.1215.73 crores during the period ended June 30, 2021.
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
The company will engage with the agency to resolve the import alert at the earliest and ensure cGMP compliance.
SteriScience will infuse an additional amount of Rs. 74.5 crore, making a total investment commitment of Rs. 114.5 crore in BSL
The company reported total income of Rs.263.60 crores during the 12 months period ended March 31, 2021
2-DG was developed by the Institute of Nuclear Medicine & Allied Sciences (INMAS), a laboratory of the Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy's
The company has posted net profit of Rs.12.12 crores for the 12 months period ended March 31, 2021
Pemetrexed is used to treat certain types of cancers such as lung cancer, mesothelioma. It is a chemotherapy drug that works by slowing or stopping the growth of cancer cells
According to IQVIA sales data for the 12 month period ending April 2021, the Ofev Capsules, 100 mg and 150 mg market achieved annual sales of approximately US $1.6 billion
Subscribe To Our Newsletter & Stay Updated
